|
|
|
|
LEADER |
02859nam a22003375i 4500 |
001 |
978-0-387-77668-2 |
005 |
20191024041233.0 |
007 |
cr nn 008mamaa |
008 |
100301s2009 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387776682
|
024 |
7 |
|
|a 10.1007/978-0-387-77667-5
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Nanotechnology in Drug Delivery
|c edited by Melgardt M. de Villiers, Pornanong Aramwit, Glen S. Kwon.
|
250 |
|
|
|a 1st ed. 2009.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2009.
|
300 |
|
|
|a XIV, 662 p. 180 illus., 29 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Biotechnology: Pharmaceutical Aspects ;
|v X
|
505 |
0 |
|
|a Fundamentals of Nanotechnology in Drug Delivery -- Physicochemical Principles of Nanosized Drug Delivery Systems -- Block Copolymer Synthesis for Nanoscale Drug and Gene Delivery -- Supercritical Fluid Technology for Nanotechnology in Drug Delivery -- Nanotubes, Nanorods, Nanofibers, and Fullerenes for Nanoscale Drug Delivery -- Drug Loading into and In Vitro Release from Nanosized Drug Delivery Systems -- Nanotechnology-Based Biosensors in Drug Delivery -- Biopharmaceutical, Physiological, and Clinical Considerations for Nanotechnology in Drug Delivery -- Nanomaterials and Biocompatibility: BioMEMS and Dendrimers -- Nanomaterials and Biocompatibility: Carbon Nanotubes and Fullerenes -- Factors Controlling Pharmacokinetics of Intravenously Injected Nanoparticulate Systems -- Controlled Release and Nanotechnology -- Nanotechnology for Intracellular Delivery and Targeting -- Nanotechnology for the Delivery of Small Molecules, Proteins and Nucleic Acids -- Nano-sized Advanced Delivery Systems as Parenteral Formulation Strategies for Hydrophobic Anti-cancer Drugs -- Engineering of Amphiphilic Block Copolymers for Drug and Gene Delivery -- PAMAM Dendrimers as Nanoscale Oral Drug Delivery Systems -- Nanoemulsions for Intravenous Drug Delivery -- Nanotechnology for Cancer Chemotherapy -- Nanotechnology for Cancer Vaccine Delivery -- Stimuli-Sensitive Nanotechnology for Drug Delivery -- A Look to the Future of Nanotechnology in Drug Delivery -- Nanotechnology in Drug Delivery: Past, Present, and Future -- Nanotechnology in Drug Development and Life Cycle Management -- Nanopharmaceuticals: Challenges and Regulatory Perspective.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Immunology.
|
650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Immunology.
|
700 |
1 |
|
|a de Villiers, Melgardt M.
|e editor.
|
700 |
1 |
|
|a Aramwit, Pornanong.
|e editor.
|
700 |
1 |
|
|a Kwon, Glen S.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-0-387-77667-5
|